Figure 2.
(a) The body weight. (b) Effect of berberine on CMDI. (c) Pathological changes of colon (compared with normal control group, ∗P < 0.05 and ∗∗P < 0.01; compared with model group, #P < 0.0 and ##P < 0.01; H&E staining, x100; A, normal group; B, model group; and C, berberine group).